Brief: Clinuvel Pharmaceuticals Posts FY Net Income Of A$36.2 Million
28/08/2025 03:47
Aug 28 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX: FY NET INCOME AUD 36.2 MILLION FY PRETAX PROFIT AUD 51.6 MILLION FULLY FRANKED FINAL DIVIDEND OF A$0.05 PER ORDINARY SHARE Further company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist